Status: Recruiting
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
The objective of this study is to assess safety and efficacy of BA3182 in Advanced Adenocarcinoma
Participants needed: 168
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: BioAtla, Inc.Updated: Sep 25, 2025Locations: 9
Eligibility criteria
Histologically or cytologically confirmed locally advanced unresectable or metas... [+5]
Patients must not have clinically significant cardiac disease. [+6]